Ohno Tetsuro, Aihara Ryuusuke, Kamiyama Yoichi, Mochiki Erito, Asao Takayuki, Kuwano Hiroyuki
Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, Japan.
Eur J Cancer. 2006 Jan;42(2):256-63. doi: 10.1016/j.ejca.2005.10.017. Epub 2005 Dec 13.
The objective of the present study was to evaluate the combination of MUC1 and the status of adhesion molecules in advanced gastric cancers as a possible predictor of patient survival. Two hundred and two paraffin-embedded specimens of gastric carcinoma were examined by immunohistochemical staining using monoclonal antibodies against MUC1 mucin, E-cadherin and beta-catenin. The expression of MUC1 was considered positive if at least 10% of the neoplastic cells were stained. E-cadherin and beta-catenin were classified into four groups. Only a membranous pattern, which was stained as strongly as normal epithelial cells, was judged as normal. The absent pattern (loss of staining), cytoplasmic pattern (cytoplasmic staining with loss of membranous expression), and heterogeneous pattern (cytoplasmic staining with preservation of membranous expression) were considered abnormal. There was a significant relationship between MUC1-positive expression and abnormal expression of E-cadherin (P=0.017). The cancer with abnormal E-cadherin expression or MUC1-positive expression increased, indicating that the cancer invasion was deep. Survival analysis of the outcome revealed that the survival time for those with abnormal E-cadherin/MUC1-positive expression was shorter than for those with other expression patterns. Multivariate analysis revealed that patients with abnormal E-cadherin/MUC1-positive expression had a poorer prognosis with significance (P<0.0001). In conclusion, abnormal E-cadherin/MUC1-positive expression pattern in advanced gastric cancer is an independent unfavorable prognostic marker.
本研究的目的是评估黏蛋白1(MUC1)与晚期胃癌中黏附分子状态的联合情况,作为患者生存的一种可能预测指标。使用抗MUC1黏蛋白、E-钙黏蛋白和β-连环蛋白的单克隆抗体,通过免疫组织化学染色对202例胃癌石蜡包埋标本进行检测。如果至少10%的肿瘤细胞被染色,则认为MUC1表达为阳性。E-钙黏蛋白和β-连环蛋白分为四组。仅将与正常上皮细胞染色强度相同的膜性模式判定为正常。无染色模式(染色缺失)、细胞质模式(细胞质染色且膜性表达缺失)和异质性模式(细胞质染色且膜性表达保留)被认为是异常的。MUC1阳性表达与E-钙黏蛋白异常表达之间存在显著相关性(P=0.017)。E-钙黏蛋白表达异常或MUC1阳性表达的癌症增多,表明癌症侵袭较深。对结果的生存分析显示,E-钙黏蛋白异常/MUC1阳性表达患者的生存时间短于其他表达模式的患者。多因素分析显示,E-钙黏蛋白异常/MUC1阳性表达的患者预后较差,差异有统计学意义(P<0.0001)。总之,晚期胃癌中E-钙黏蛋白异常/MUC1阳性表达模式是一个独立的不良预后标志物。